APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetic Disease Diagnostic

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genetic Disease Diagnostic Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchGenetic Disease Diagnostic Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetic Disease Diagnostic Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Genetic Disease Diagnostic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetic Disease Diagnostic Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetic Disease Diagnostic Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Genetic Disease Diagnostic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genetic Disease Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genetic Disease Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetic Disease Diagnostic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genetic Disease Diagnostic market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genetic Disease Diagnostic market include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Genetic Disease Diagnostic market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genetic Disease Diagnostic and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genetic Disease Diagnostic revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Genetic Disease Diagnostic market.

Genetic Disease Diagnostic Segment by Company

Abbott

PerkinElmer

Roche Diagnostics

Bio Rad

Thermo Fisher Scientific

BGI Group

Berry Genomics

Da An Gene Co., Ltd.

Illumina

CapitalBio Technology

Genetic Disease Diagnostic Segment by Type

Prenatal Diagnosis

Screening for Single Gene Genetic Disease

Preimplantation Genetic Testing

Others

Genetic Disease Diagnostic Segment by Application

Hospital

Medical Laboratory

Others

Genetic Disease Diagnostic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genetic Disease Diagnostic status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Genetic Disease Diagnostic key companies, revenue, market share, and recent developments.

3. To split the Genetic Disease Diagnostic breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Genetic Disease Diagnostic market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genetic Disease Diagnostic significant trends, drivers, influence factors in global and regions.

6. To analyze Genetic Disease Diagnostic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Disease Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetic Disease Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Disease Diagnostic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genetic Disease Diagnostic industry.

Chapter 3: Detailed analysis of Genetic Disease Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Genetic Disease Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Genetic Disease Diagnostic in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genetic Disease Diagnostic Industry Trends Table 2. Genetic Disease Diagnostic Industry Drivers Table 3. Genetic Disease Diagnostic Industry Opportunities and Challenges Table 4. Genetic Disease Diagnostic Industry Restraints Table 5. Global Genetic Disease Diagnostic Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genetic Disease Diagnostic Revenue Share by Company (2021-2026) Table 7. Global Genetic Disease Diagnostic Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Genetic Disease Diagnostic Key Company Manufacturing Base & Headquarters Table 9. Global Genetic Disease Diagnostic Company, Product Type & Application Table 10. Global Genetic Disease Diagnostic Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Genetic Disease Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Prenatal Diagnosis Table 15. Significant Companies of Screening for Single Gene Genetic Disease Table 16. Significant Companies of Preimplantation Genetic Testing Table 17. Significant Companies of Others Table 18. Global Genetic Disease Diagnostic Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Genetic Disease Diagnostic Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Genetic Disease Diagnostic Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Genetic Disease Diagnostic Sales Value Share by Type (2021-2026) Table 22. Global Genetic Disease Diagnostic Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Medical Laboratory Table 25. Significant Companies of Others Table 26. Global Genetic Disease Diagnostic Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Genetic Disease Diagnostic Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Genetic Disease Diagnostic Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Genetic Disease Diagnostic Sales Value Share by Application (2021-2026) Table 30. Global Genetic Disease Diagnostic Sales Value Share by Application (2027-2032) Table 31. Global Genetic Disease Diagnostic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Genetic Disease Diagnostic Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Genetic Disease Diagnostic Sales Value Share by Region (2021-2026) Table 34. Global Genetic Disease Diagnostic Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Genetic Disease Diagnostic Sales Value Share by Region (2027-2032) Table 36. Global Genetic Disease Diagnostic Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Genetic Disease Diagnostic Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Genetic Disease Diagnostic Sales Value Market Share by Country (2021-2026) Table 39. Global Genetic Disease Diagnostic Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Genetic Disease Diagnostic Sales Value Market Share by Country (2027-2032) Table 41. Abbott Company Information Table 42. Abbott Business Overview Table 43. Abbott Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Abbott Genetic Disease Diagnostic Product Portfolio Table 45. Abbott Recent Development Table 46. PerkinElmer Company Information Table 47. PerkinElmer Business Overview Table 48. PerkinElmer Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. PerkinElmer Genetic Disease Diagnostic Product Portfolio Table 50. PerkinElmer Recent Development Table 51. Roche Diagnostics Company Information Table 52. Roche Diagnostics Business Overview Table 53. Roche Diagnostics Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Roche Diagnostics Genetic Disease Diagnostic Product Portfolio Table 55. Roche Diagnostics Recent Development Table 56. Bio Rad Company Information Table 57. Bio Rad Business Overview Table 58. Bio Rad Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bio Rad Genetic Disease Diagnostic Product Portfolio Table 60. Bio Rad Recent Development Table 61. Thermo Fisher Scientific Company Information Table 62. Thermo Fisher Scientific Business Overview Table 63. Thermo Fisher Scientific Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Thermo Fisher Scientific Genetic Disease Diagnostic Product Portfolio Table 65. Thermo Fisher Scientific Recent Development Table 66. BGI Group Company Information Table 67. BGI Group Business Overview Table 68. BGI Group Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. BGI Group Genetic Disease Diagnostic Product Portfolio Table 70. BGI Group Recent Development Table 71. Berry Genomics Company Information Table 72. Berry Genomics Business Overview Table 73. Berry Genomics Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Berry Genomics Genetic Disease Diagnostic Product Portfolio Table 75. Berry Genomics Recent Development Table 76. Da An Gene Co., Ltd. Company Information Table 77. Da An Gene Co., Ltd. Business Overview Table 78. Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Da An Gene Co., Ltd. Genetic Disease Diagnostic Product Portfolio Table 80. Da An Gene Co., Ltd. Recent Development Table 81. Illumina Company Information Table 82. Illumina Business Overview Table 83. Illumina Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Illumina Genetic Disease Diagnostic Product Portfolio Table 85. Illumina Recent Development Table 86. CapitalBio Technology Company Information Table 87. CapitalBio Technology Business Overview Table 88. CapitalBio Technology Genetic Disease Diagnostic Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CapitalBio Technology Genetic Disease Diagnostic Product Portfolio Table 90. CapitalBio Technology Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Genetic Disease Diagnostic Product Image Figure 2. Global Genetic Disease Diagnostic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetic Disease Diagnostic Market Size (2021-2032) & (US$ Million) Figure 4. Global Genetic Disease Diagnostic Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Prenatal Diagnosis Image Figure 8. Screening for Single Gene Genetic Disease Image Figure 9. Preimplantation Genetic Testing Image Figure 10. Others Image Figure 11. Global Genetic Disease Diagnostic Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Genetic Disease Diagnostic Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Genetic Disease Diagnostic Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Medical Laboratory Image Figure 16. Others Image Figure 17. Global Genetic Disease Diagnostic Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Genetic Disease Diagnostic Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Genetic Disease Diagnostic Sales Value Share by Application (2021-2032) Figure 20. Global Genetic Disease Diagnostic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Genetic Disease Diagnostic Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Genetic Disease Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 23. North America Genetic Disease Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Genetic Disease Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Genetic Disease Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Genetic Disease Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Genetic Disease Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Genetic Disease Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 29. South America Genetic Disease Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Genetic Disease Diagnostic Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Genetic Disease Diagnostic Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Prenatal Diagnosis
  • Screening for Single Gene Genetic Disease
  • Preimplantation Genetic Testing
  • Others
Applications
  • Hospital
  • Medical Laboratory
  • Others
Companies covered
  • Abbott
  • PerkinElmer
  • Roche Diagnostics
  • Bio Rad
  • Thermo Fisher Scientific
  • BGI Group
  • Berry Genomics
  • Da An Gene Co., Ltd.
  • Illumina
  • CapitalBio Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genetic Disease Diagnostic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genetic Disease Diagnostic Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Genetic Disease Diagnostic Market Dynamics
  1. 2.1 Genetic Disease Diagnostic Industry Trends
  2. 2.2 Genetic Disease Diagnostic Industry Drivers
  3. 2.3 Genetic Disease Diagnostic Industry Opportunities and Challenges
  4. 2.4 Genetic Disease Diagnostic Industry Restraints
3 Genetic Disease Diagnostic Market by Company
  1. 3.1 Global Genetic Disease Diagnostic Company Revenue Ranking in 2025
  2. 3.2 Global Genetic Disease Diagnostic Revenue by Company (2021-2026)
  3. 3.3 Global Genetic Disease Diagnostic Company Ranking (2024-2026)
  4. 3.4 Global Genetic Disease Diagnostic Company Manufacturing Base and Headquarters
  5. 3.5 Global Genetic Disease Diagnostic Company Product Type and Application
  6. 3.6 Global Genetic Disease Diagnostic Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Genetic Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Genetic Disease Diagnostic Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Genetic Disease Diagnostic Market by Type
  1. 4.1 Genetic Disease Diagnostic Type Introduction
  2. 4.1.1 Prenatal Diagnosis
  3. 4.1.2 Screening for Single Gene Genetic Disease
  4. 4.1.3 Preimplantation Genetic Testing
  5. 4.1.4 Others
  6. 4.2 Global Genetic Disease Diagnostic Sales Value by Type
  7. 4.2.1 Global Genetic Disease Diagnostic Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Genetic Disease Diagnostic Sales Value by Type (2021-2032)
  9. 4.2.3 Global Genetic Disease Diagnostic Sales Value Share by Type (2021-2032)
5 Genetic Disease Diagnostic Market by Application
  1. 5.1 Genetic Disease Diagnostic Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Medical Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Genetic Disease Diagnostic Sales Value by Application
  6. 5.2.1 Global Genetic Disease Diagnostic Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Genetic Disease Diagnostic Sales Value by Application (2021-2032)
  8. 5.2.3 Global Genetic Disease Diagnostic Sales Value Share by Application (2021-2032)
6 Genetic Disease Diagnostic Regional Value Analysis
  1. 6.1 Global Genetic Disease Diagnostic Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genetic Disease Diagnostic Sales Value by Region (2021-2032)
  3. 6.2.1 Global Genetic Disease Diagnostic Sales Value by Region: 2021-2026
  4. 6.2.2 Global Genetic Disease Diagnostic Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genetic Disease Diagnostic Sales Value (2021-2032)
  7. 6.3.2 North America Genetic Disease Diagnostic Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Genetic Disease Diagnostic Sales Value (2021-2032)
  10. 6.4.2 Europe Genetic Disease Diagnostic Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Genetic Disease Diagnostic Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Genetic Disease Diagnostic Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Genetic Disease Diagnostic Sales Value (2021-2032)
  16. 6.6.2 South America Genetic Disease Diagnostic Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Genetic Disease Diagnostic Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Genetic Disease Diagnostic Sales Value Share by Country, 2025 VS 2032
7 Genetic Disease Diagnostic Country-level Value Analysis
  1. 7.1 Global Genetic Disease Diagnostic Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genetic Disease Diagnostic Sales Value by Country (2021-2032)
  3. 7.2.1 Global Genetic Disease Diagnostic Sales Value by Country (2021-2026)
  4. 7.2.2 Global Genetic Disease Diagnostic Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Genetic Disease Diagnostic Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Genetic Disease Diagnostic Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Genetic Disease Diagnostic Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Genetic Disease Diagnostic Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 PerkinElmer
  8. 8.2.1 PerkinElmer Company Information
  9. 8.2.2 PerkinElmer Business Overview
  10. 8.2.3 PerkinElmer Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PerkinElmer Genetic Disease Diagnostic Product Portfolio
  12. 8.2.5 PerkinElmer Recent Developments
  13. 8.3 Roche Diagnostics
  14. 8.3.1 Roche Diagnostics Company Information
  15. 8.3.2 Roche Diagnostics Business Overview
  16. 8.3.3 Roche Diagnostics Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Diagnostics Genetic Disease Diagnostic Product Portfolio
  18. 8.3.5 Roche Diagnostics Recent Developments
  19. 8.4 Bio Rad
  20. 8.4.1 Bio Rad Company Information
  21. 8.4.2 Bio Rad Business Overview
  22. 8.4.3 Bio Rad Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio Rad Genetic Disease Diagnostic Product Portfolio
  24. 8.4.5 Bio Rad Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 BGI Group
  32. 8.6.1 BGI Group Company Information
  33. 8.6.2 BGI Group Business Overview
  34. 8.6.3 BGI Group Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BGI Group Genetic Disease Diagnostic Product Portfolio
  36. 8.6.5 BGI Group Recent Developments
  37. 8.7 Berry Genomics
  38. 8.7.1 Berry Genomics Company Information
  39. 8.7.2 Berry Genomics Business Overview
  40. 8.7.3 Berry Genomics Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Berry Genomics Genetic Disease Diagnostic Product Portfolio
  42. 8.7.5 Berry Genomics Recent Developments
  43. 8.8 Da An Gene Co., Ltd.
  44. 8.8.1 Da An Gene Co., Ltd. Company Information
  45. 8.8.2 Da An Gene Co., Ltd. Business Overview
  46. 8.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Product Portfolio
  48. 8.8.5 Da An Gene Co., Ltd. Recent Developments
  49. 8.9 Illumina
  50. 8.9.1 Illumina Company Information
  51. 8.9.2 Illumina Business Overview
  52. 8.9.3 Illumina Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Illumina Genetic Disease Diagnostic Product Portfolio
  54. 8.9.5 Illumina Recent Developments
  55. 8.10 CapitalBio Technology
  56. 8.10.1 CapitalBio Technology Company Information
  57. 8.10.2 CapitalBio Technology Business Overview
  58. 8.10.3 CapitalBio Technology Genetic Disease Diagnostic Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CapitalBio Technology Genetic Disease Diagnostic Product Portfolio
  60. 8.10.5 CapitalBio Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst